BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37064153)

  • 1. Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer.
    Xiao Z; Wang X; Chen X; Zhou J; Zhu H; Zhang J; Deng W
    Front Oncol; 2023; 13():1064343. PubMed ID: 37064153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma.
    Zhao X; Zhou Y; Liu B; Shen Y; Qian J; Zhang X; Zhao H
    Med Sci Monit; 2023 Mar; 29():e939442. PubMed ID: 36992543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.
    Ming-Sheng F; Mei-Ling D; Xun-Quan C; Yuan-Xin H; Wei-Jie Z; Qin-Cong P
    Can J Gastroenterol Hepatol; 2022; 2022():3109165. PubMed ID: 35028301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients.
    Ying HQ; Deng QW; He BS; Pan YQ; Wang F; Sun HL; Chen J; Liu X; Wang SK
    Med Oncol; 2014 Dec; 31(12):305. PubMed ID: 25355641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study.
    Wang Y; Zhang H; Yang Y; Zhang T; Ma X
    Front Oncol; 2019; 9():995. PubMed ID: 31649874
    [No Abstract]   [Full Text] [Related]  

  • 8. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients.
    Shang QX; Yang YS; Hu WP; Yuan Y; He Y; Zhao JY; Ji AF; Chen LQ
    Transl Cancer Res; 2020 Jun; 9(6):3903-3914. PubMed ID: 35117757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
    Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
    Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between systemic inflammatory response, screen detection and outcome in colorectal cancer.
    Johnstone MS; McSorley ST; McMillan DC; Horgan PG; Mansouri D
    Colorectal Dis; 2024 Jan; 26(1):81-94. PubMed ID: 38095280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival.
    Peng J; Li H; Ou Q; Lin J; Wu X; Lu Z; Yuan Y; Wan D; Fang Y; Pan Z
    Onco Targets Ther; 2017; 10():3789-3799. PubMed ID: 28794643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios.
    Zager Y; Hoffman A; Dreznik Y; Jacoby H; Cordoba M; Horesh N; Nevler A; Gutman M; Berger Y
    Surg Oncol; 2020 Dec; 35():321-327. PubMed ID: 32977104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer.
    Chan JC; Chan DL; Diakos CI; Engel A; Pavlakis N; Gill A; Clarke SJ
    Ann Surg; 2017 Mar; 265(3):539-546. PubMed ID: 27070934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Combined LMR and CEA Dynamic Monitoring in Postoperative Colorectal Cancer Patients.
    Chen S; Zhang J; Qian C; Qi X; Mao Y; Lu T
    J Inflamm Res; 2023; 16():4229-4250. PubMed ID: 37772275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer.
    Li X; Guo D; Chu L; Huang Y; Zhang F; Li W; Chen J
    Cancer Manag Res; 2019; 11():9631-9640. PubMed ID: 32009818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy.
    Hirahara N; Matsubara T; Mizota Y; Ishibashi S; Tajima Y
    BMC Surg; 2016 Sep; 16(1):66. PubMed ID: 27650456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic efficacy of inflammation-based markers in patients with curative colorectal cancer resection.
    Akgül Ö; Çetinkaya E; Yalaza M; Özden S; Tez M
    World J Gastrointest Oncol; 2017 Jul; 9(7):300-307. PubMed ID: 28808503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Importance of Systemic Inflammation Markers in the Survival of Patients with Complicated Colorectal Cancer, Operated in Emergency.
    Constantin GB; Firescu D; Voicu D; Ștefănescu B; Serban RMC; Panaitescu E; Bîrlă R; Constantinoiu S
    Chirurgia (Bucur); 2020; 115(1):39-49. PubMed ID: 32155398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.